Synthesis, Characterization, and Multidimensional In Silico Evaluation of Novel Etodolac-Based 1,3,4-Oxadiazole Derivatives as Potential Anticancer Agents
Organics · 07.04.2026 · 7 (2) · 15
DOI: 10.3390/org7020015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organics, online erschienen am 07.04.2026. Verfasst von Tiba M. Hameed und 4 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A new series of eight novel etodolac-based 1,3,4-oxadiazoles was synthesized, characterized, and tested in silico in multidimensional routes, starting with etodolac, a well-known nonsteroidal anti-inflammatory medication (NSAID). In silico studies were performed prior to synthesis using the molecular docking technique in CCDC GOLD suite software (2025.3) to assess the interactions with two key targets involved in cancer pathogenesis: the crystal structure of the epidermal growth factor receptor EGFR tyrosine kinase domain (PDB ID: 4HJO) and the matrix metalloproteinase (MMP-9) complex (PDB ID: 5CUH). ADME studies were performed to assess the physicochemical properties of the synthesized molecules. Importantly, biotransformation prediction also indicated that the derivatives possess high metabolic stability, with hydroxylation of the thio-ether group as the primary predicted biotransformation route. All compounds were characterized using melting point, FT-IR, 1H-NMR, and 13C-NMR spectroscopy. In vitro and/or in vivo experiments are needed to confirm this preliminary anticancer study.
Zitieren
APA
Hameed, T. M., Hashim, R. M., Abed, S. J., Ridha, R. H., & Baqer, O. A. (2026). Synthesis, Characterization, and Multidimensional In Silico Evaluation of Novel Etodolac-Based 1,3,4-Oxadiazole Derivatives as Potential Anticancer Agents. Organics, 7(2), 15. https://doi.org/10.3390/org7020015
Vancouver
Hameed TM, Hashim RM, Abed SJ, Ridha RH, Baqer OA. Synthesis, Characterization, and Multidimensional In Silico Evaluation of Novel Etodolac-Based 1,3,4-Oxadiazole Derivatives as Potential Anticancer Agents. Organics. 2026;7(2):15. doi:10.3390/org7020015
BibTeX
@article{Hameed2026,
author = {Hameed, Tiba M. and Hashim, Rafid M. and Abed, S. J. and Ridha, Raneen Hashim and Baqer, O. Al-Mohammed},
title = {Synthesis, Characterization, and Multidimensional In Silico Evaluation of Novel Etodolac-Based 1,3,4-Oxadiazole Derivatives as Potential Anticancer Agents},
journal = {Organics},
year = {2026},
volume = {7},
number = {2},
pages = {15},
doi = {10.3390/org7020015}
}
EUVIMED